[go: up one dir, main page]

BR9709792A - Use of H2 antagonists for the manufacture of a topical composition for the treatment of colds - Google Patents

Use of H2 antagonists for the manufacture of a topical composition for the treatment of colds

Info

Publication number
BR9709792A
BR9709792A BR9709792A BR9709792A BR9709792A BR 9709792 A BR9709792 A BR 9709792A BR 9709792 A BR9709792 A BR 9709792A BR 9709792 A BR9709792 A BR 9709792A BR 9709792 A BR9709792 A BR 9709792A
Authority
BR
Brazil
Prior art keywords
colds
antagonists
manufacture
treatment
topical composition
Prior art date
Application number
BR9709792A
Other languages
Portuguese (pt)
Inventor
Robert Ernest Singer Jr
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9709792A publication Critical patent/BR9709792A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9709792A 1996-06-12 1997-06-10 Use of H2 antagonists for the manufacture of a topical composition for the treatment of colds BR9709792A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66238996A 1996-06-12 1996-06-12
PCT/US1997/009977 WO1997047292A1 (en) 1996-06-12 1997-06-10 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds

Publications (1)

Publication Number Publication Date
BR9709792A true BR9709792A (en) 1999-08-10

Family

ID=24657514

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709792A BR9709792A (en) 1996-06-12 1997-06-10 Use of H2 antagonists for the manufacture of a topical composition for the treatment of colds

Country Status (8)

Country Link
EP (1) EP0954294A1 (en)
JP (1) JPH11513035A (en)
CN (1) CN1221338A (en)
AU (1) AU3306997A (en)
BR (1) BR9709792A (en)
CA (1) CA2257990A1 (en)
ID (1) ID19099A (en)
WO (1) WO1997047292A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846478B1 (en) 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
JP2003529590A (en) * 2000-03-21 2003-10-07 アスション デヴェロップメント エーピーエス Chemical complex comprising pyridine carboxy derivative and H2 histamine receptor antagonist
PE20020102A1 (en) 2000-06-30 2002-03-06 Procter & Gamble TOPICAL ORAL COMPOSITION INCLUDING A MODULATING AGENT OF THE HOST RESPONSE TO PERIODONTAL PATHOGENS
AU2001271545A1 (en) * 2000-06-30 2002-01-14 The Procter And Gamble Company Promoting whole body health
JP2003321366A (en) * 2002-04-30 2003-11-11 Ucb Japan Kk Agent for preventing or treating inflammatory bowel disease
ITMI20031640A1 (en) * 2003-08-08 2005-02-09 Mipharm S P A BASE FOR BIOADHESIVE GEL.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749700A (en) * 1984-10-23 1988-06-07 Nastech Pharmaceutical Co, Inc. Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same
WO1992015332A1 (en) * 1991-03-04 1992-09-17 Warner-Lambert Company Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis

Also Published As

Publication number Publication date
ID19099A (en) 1998-06-11
WO1997047292A1 (en) 1997-12-18
JPH11513035A (en) 1999-11-09
CA2257990A1 (en) 1997-12-18
EP0954294A1 (en) 1999-11-10
AU3306997A (en) 1998-01-07
CN1221338A (en) 1999-06-30

Similar Documents

Publication Publication Date Title
PT977748E (en) SUBSTITUTED BENZOPIRAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATION
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
EE04390B1 (en) Topical preparation for the treatment of dermatological conditions
HUP0100765A3 (en) Composition for the treatment of halitosis
HUP0104676A3 (en) Compositions for the treatment of anorectal disorders and their use
BR9711530A (en) Combination of therapy for the treatment of psychoses
NO20005913L (en) Medicinal Composition
FI972387A0 (en) Parasiticidal compositions for application to the skin
PT998272E (en) PHARMACEUTICAL COMPOSITION FOR COMBINATION OF PIPERIDINOALCANOL DECONGESTIONANT
HUP0103621A3 (en) Fentanyl composition for the treatment of acute pain
FI950797L (en) Antiperspirant deodorant composition
FI950798L (en) Antiperspirant deodorant composition
DE69731542D1 (en) PHOTOCATALYTIC COMPOSITION
FI950799A0 (en) Antiperspirant deodorant composition
PT1206436E (en) RETINOIDS FOR THE TREATMENT OF ENFISEMA
DE69700310D1 (en) Anti-rust composition
DK1023035T3 (en) The oral composition
BR9706908A (en) Compositions for the treatment of renal failure comprising l-carnosine
BR9707078A (en) Body soap composition
PT983275E (en) NEW DERIVATIVES OF TRIPTOLIDO ADVANTAGES FOR THE TREATMENT OF AUTOMATIC DISEASES
PT1014927E (en) USE OF SHOGAOIS AND GINGERIALS FOR THE PREPARATION OF DEODORIZING COMPOSITIONS
IS5951A (en) 5HT1 antidepressant for the treatment of depression
BR9709792A (en) Use of H2 antagonists for the manufacture of a topical composition for the treatment of colds
BR9806083A (en) Pharmaceutical composition for the treatment of hapattite c
PT928183E (en) USES OF 1-HYDROXYL-2-PYRIDONENE FOR THE TREATMENT OF SEBORROIC DERMATITIS

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal